Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Test Your Knowledge
Quiz: FOLFIRINOX Outshines Gemcitabine in Pancreatic Cancer
04/17/2019
True or false: Six months of postoperative treatment with the combination of fluorouracil, leucovorin, irinotecan and oxaliplatin (ie, FOLFIRINOX) improved survival rates over conventional gemcitabine therapy in a recent study of patients...
True or false: Six months of postoperative treatment with the combination of fluorouracil, leucovorin, irinotecan and oxaliplatin (ie, FOLFIRINOX) improved survival rates over conventional gemcitabine therapy in a recent study of patients...
True or false: Six months of...
04/17/2019
Oncology
Videos
Jordan D. Berlin, MD, on the Role of Pre-Op Chemo in Pancreatic Cancer
04/17/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the role of pre-surgery chemotherapy in pancreatic cancer.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the role of pre-surgery chemotherapy in pancreatic cancer.
At the 2019 Great Debates &...
04/17/2019
Oncology
Interview
Immunotherapy Combo Halts Tumor Growth in Patients With Liver Cancer
04/09/2019
Gen-Sheng Feng, PhD, discusses the potential efficacy of a combination immunotherapy that suppresses liver tumor growth.
Gen-Sheng Feng, PhD, discusses the potential efficacy of a combination immunotherapy that suppresses liver tumor growth.
Gen-Sheng Feng, PhD, discusses...
04/09/2019
Oncology
Videos
What to Expect at the 2019 ESMO World Congress on Gastrointestinal Cancer
04/04/2019
Eric Van Cutsem, MD, PhD, talks about what attendees of World GI can anticipate at this year's meeting in Barcelona, Spain, July 3-6, 2019.
Eric Van Cutsem, MD, PhD, talks about what attendees of World GI can anticipate at this year's meeting in Barcelona, Spain, July 3-6, 2019.
Eric Van Cutsem, MD, PhD, talks...
04/04/2019
Oncology
Videos
Jordan D. Berlin, MD, on First-Line Therapy Options for Pancreatic Cancer
04/03/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the standard first-line therapies available for pancreatic cancer.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the standard first-line therapies available for pancreatic cancer.
At the 2019 Great Debates &...
04/03/2019
Oncology
Videos
Jordan D. Berlin, MD, Talks Second-Line PRRT Use in Patients With pNETs
03/30/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed using second-line PRRT in patients with pNETs.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed using second-line PRRT in patients with pNETs.
At the 2019 Great Debates &...
03/30/2019
Oncology
Videos
Eric Van Cutsem, MD, PhD, Discusses the Novel Therapies and Targets in Metastatic CRC
03/29/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Van Cutsem talked about the novel therapies and targets in metastatic CRC.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Van Cutsem talked about the novel therapies and targets in metastatic CRC.
At the 2019 Great Debates &...
03/29/2019
Oncology
Videos
David Ilson, MD, PhD, on Making Treatment Decisions for Patients With Esophageal Cancer
03/29/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Ilson discussed factors to consider when treating patients with esophageal cancer.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Ilson discussed factors to consider when treating patients with esophageal cancer.
At the 2019 Great Debates &...
03/29/2019
Oncology
Experts Debate Evidence For and Against HIPEC Use in CRC Peritoneal Disease
03/29/2019
Michael A. Choti, MD, and Andrea Cercek, MD, presented their arguments for and against the use of HIPEC for CRC peritoneal carcinomatosis at the 2019 Great Debates and Updates in GI Malignancies meeting.
Michael A. Choti, MD, and Andrea Cercek, MD, presented their arguments for and against the use of HIPEC for CRC peritoneal carcinomatosis at the 2019 Great Debates and Updates in GI Malignancies meeting.
Michael A. Choti, MD, and Andrea...
03/29/2019
Oncology
Interview
Careful Scrutiny of Early Endoscopy Results Critical for Assessment in Barrett's Esophagus
03/18/2019
Madhav Desai, MD, MPH, talks about the prevalence patterns of Barrett's esophagus–associated dysplasia detected via index endoscopy.
Madhav Desai, MD, MPH, talks about the prevalence patterns of Barrett's esophagus–associated dysplasia detected via index endoscopy.
Madhav Desai, MD, MPH, talks...
03/18/2019
Oncology

Advertisement

Advertisement

Advertisement

Section Editor

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center, New York

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement